Janna E. Quinn

1.3k total citations
18 papers, 1.0k citations indexed

About

Janna E. Quinn is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Janna E. Quinn has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Janna E. Quinn's work include Prostate Cancer Treatment and Research (10 papers), Bone health and treatments (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Janna E. Quinn is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Bone health and treatments (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Janna E. Quinn collaborates with scholars based in United States, Germany and Australia. Janna E. Quinn's co-authors include Robert L. Vessella, Eva Corey, Lisha G. Brown, Kent R. Buhler, Martine P. Roudier, Peter S. Nelson, Celestia S. Higano, Lawrence D. True, Martin Poot and Jill A. Macoska and has published in prestigious journals such as Cancer Research, The Journal of Urology and American Journal Of Pathology.

In The Last Decade

Janna E. Quinn

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janna E. Quinn United States 15 540 493 417 282 141 18 1.0k
E. Edmund Kim United States 6 276 0.5× 480 1.0× 374 0.9× 373 1.3× 295 2.1× 7 1.0k
Yoshio Tanji Japan 13 745 1.4× 131 0.3× 372 0.9× 133 0.5× 426 3.0× 24 1.2k
Hannah K. Brown United Kingdom 21 749 1.4× 336 0.7× 526 1.3× 177 0.6× 355 2.5× 24 1.3k
Chunrong Li United States 19 556 1.0× 256 0.5× 486 1.2× 214 0.8× 121 0.9× 38 1.1k
Kelly Waldeck Australia 13 361 0.7× 201 0.4× 350 0.8× 150 0.5× 123 0.9× 24 784
Todd R. Palmby United States 18 541 1.0× 355 0.7× 927 2.2× 173 0.6× 179 1.3× 19 1.6k
Cataldo Bianco Italy 24 765 1.4× 427 0.9× 757 1.8× 169 0.6× 252 1.8× 37 1.5k
Martin Zweifel Switzerland 17 229 0.4× 119 0.2× 341 0.8× 146 0.5× 168 1.2× 37 987
Giovanni Allevi Italy 17 603 1.1× 136 0.3× 437 1.0× 115 0.4× 669 4.7× 36 1.2k
CL Arteaga United States 12 544 1.0× 316 0.6× 429 1.0× 139 0.5× 175 1.2× 27 946

Countries citing papers authored by Janna E. Quinn

Since Specialization
Citations

This map shows the geographic impact of Janna E. Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janna E. Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janna E. Quinn more than expected).

Fields of papers citing papers by Janna E. Quinn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janna E. Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janna E. Quinn. The network helps show where Janna E. Quinn may publish in the future.

Co-authorship network of co-authors of Janna E. Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Janna E. Quinn. A scholar is included among the top collaborators of Janna E. Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janna E. Quinn. Janna E. Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Quinn, Janna E., Lisha G. Brown, Jinglong Zhang, et al.. (2005). Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms. Prostate Cancer and Prostatic Diseases. 8(3). 253–259. 26 indexed citations
2.
Corey, Eva, Lisha G. Brown, Jeffrey Kiefer, et al.. (2005). Osteoprotegerin in Prostate Cancer Bone Metastasis. Cancer Research. 65(5). 1710–1718. 85 indexed citations
3.
Liu, Alvin Y., Kristen D. Brubaker, Young Ah Goo, et al.. (2004). Lineage relationship between LNCaP and LNCaP‐derived prostate cancer cell lines. The Prostate. 60(2). 98–108. 42 indexed citations
4.
5.
Chaı̈b, Hassan, James W. MacDonald, Robert L. Vessella, et al.. (2003). Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors. Genes Chromosomes and Cancer. 37(3). 306–313. 20 indexed citations
6.
Clegg, Nigel, Camari Ferguson, Lawrence D. True, et al.. (2003). Molecular characterization of prostatic small‐cell neuroendocrine carcinoma. The Prostate. 55(1). 55–64. 60 indexed citations
7.
Corey, Eva, Janna E. Quinn, Kent R. Buhler, et al.. (2003). LuCaP 35: A new model of prostate cancer progression to androgen independence. The Prostate. 55(4). 239–246. 120 indexed citations
8.
Corey, Eva, Janna E. Quinn, & Robert L. Vessella. (2003). A novel method of generating prostate cancer metastases from orthotopic implants. The Prostate. 56(2). 110–114. 21 indexed citations
9.
Corey, Eva, Lisha G. Brown, Janna E. Quinn, et al.. (2003). Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.. PubMed. 9(1). 295–306. 193 indexed citations
10.
Wilbur, D. Scott, Ming‐Kuan Chyan, Donald K. Hamlin, et al.. (2003). Reagents for Astatination of Biomolecules:  Comparison of the in Vivo Distribution and Stability of Some Radioiodinated/Astatinated Benzamidyl andnido-Carboranyl Compounds. Bioconjugate Chemistry. 15(1). 203–223. 92 indexed citations
11.
Pfitzenmaier, Jesco, Janna E. Quinn, Jian Zhang, et al.. (2003). Characterization of C4–2 Prostate Cancer Bone Metastases and Their Response to Castration. Journal of Bone and Mineral Research. 18(10). 1882–1888. 39 indexed citations
12.
Chaı̈b, Hassan, James W. MacDonald, Robert L. Vessella, et al.. (2003). Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors. European Urology Supplements. 2(6). 61–61. 2 indexed citations
13.
Corey, Eva, Janna E. Quinn, Franck Bladou, et al.. (2002). Establishment and characterization of osseous prostate cancer models: Intra‐tibial injection of human prostate cancer cells. The Prostate. 52(1). 20–33. 153 indexed citations
14.
True, Lawrence D., Kent R. Buhler, Janna E. Quinn, et al.. (2002). A Neuroendocrine/Small Cell Prostate Carcinoma Xenograft—LuCaP 49. American Journal Of Pathology. 161(2). 705–715. 40 indexed citations
15.
Wilbur, D. Scott, Donald K. Hamlin, Damon L. Meyer, et al.. (2002). Streptavidin in Antibody Pretargeting. 3. Comparison of Biotin Binding and Tissue Localization of 1,2-Cyclohexanedione and Succinic Anhydride Modified Recombinant Streptavidin. Bioconjugate Chemistry. 13(3). 611–620. 11 indexed citations
16.
Corey, Eva, Janna E. Quinn, Mary J. Emond, et al.. (2002). Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol.. PubMed. 8(4). 1003–7. 43 indexed citations
17.
Melchior, S., Lisha G. Brown, William D. Figg, et al.. (1999). Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.. International Journal of Oncology. 14(3). 501–8. 42 indexed citations
18.
Buhler, Kent R., Janna E. Quinn, S Whitney, et al.. (1999). THE LuCaP SERIES OF HUMAN PROSTATE CANCER XENOGRAFTS. The Journal of Urology. 58–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Edmund Kim Breakdown of academic impact, for papers by Yoshio Tanji Breakdown of academic impact, for papers by Hannah K. Brown Breakdown of academic impact, for papers by Chunrong Li Breakdown of academic impact, for papers by Kelly Waldeck Breakdown of academic impact, for papers by Todd R. Palmby Breakdown of academic impact, for papers by Cataldo Bianco Breakdown of academic impact, for papers by Martin Zweifel Breakdown of academic impact, for papers by Giovanni Allevi Breakdown of academic impact, for papers by CL Arteaga
Rankless by CCL
2026